相关实验视频
Updated: May 12, 2026

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
10.9K
基酸功能化的小胞体双重准酸输送器和多糖化物用于siRNA输送到棕藻中
Naoto Yoshinaga1,2, Takaaki Miyamoto1, Mami Goto1
1Biomacromolecule Research Team, RIKEN Center for Sustainable Resource Science, Wako-shi, Saitama 351-0198, Japan.
JACS Au
|April 26, 2024
概括
研究人员开发了新型siRNA载细胞,以克服棕藻.
科学领域:
- 海洋生物学 海洋生物学
- 生物技术是生物技术.
- 分子生物学分子生物学
背景情况:
- 棕藻在生态和经济上都很重要,但它们独特的生物学的了解很少.
- 了解棕藻的分子机制需要有效的基因表达控制.
- 现有的遗传工具受到藻类坚固的细胞结构的限制.
研究的目的:
- 开发一种用于棕藻中基因沉默的新型传递系统.
- 调查基于的细胞在siRNA传递方面的潜力.
- 探索特定基因在棕藻生长中的功能作用.
主要方法:
- 设计的基于的小,载有小干扰RNA (siRNA).
- 用酸 (PBA) 连接体装饰的体,用于增强细胞吸收.
- 在实验中使用了棕色藻类*Ectocarpus siliculosus* (*E. siliculosus*) 的模型.
- 用于诱导与auxin生物合成相关的基因沉默的微粒.
主要成果:
- 通过细胞壁相互作用和输送器识别,PBA配体促进了小细胞的吸收.
- 通过基因沉默成功实现了E. siliculosus*的暂时生长抑制.
- 证明有效的siRNA传递和基因沉默,没有永久的基因组改变.
结论:
- 开发了一种可行且有效的siRNA传递系统,用于棕藻.
- 为进一步探索棕藻分子生物学和特征铺平了道路.
- 突出了PBA-ligand装饰的细胞在藻类中的基因操纵潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

